E. Durmuş Çalışkan Et Al. , "Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study," GROWTH HORMONE & IGF RESEARCH , vol.67, 2022
Durmuş Çalışkan, E. Et Al. 2022. Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study. GROWTH HORMONE & IGF RESEARCH , vol.67 .
Durmuş Çalışkan, E., Atmaca, A., Kefeli, M., Çalışkan, S., Mete, O., Aslan, K., ... Fidan, M.(2022). Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study. GROWTH HORMONE & IGF RESEARCH , vol.67.
Durmuş Çalışkan, Elif Et Al. "Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study," GROWTH HORMONE & IGF RESEARCH , vol.67, 2022
Durmuş Çalışkan, Elif D. Et Al. "Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study." GROWTH HORMONE & IGF RESEARCH , vol.67, 2022
Durmuş Çalışkan, E. Et Al. (2022) . "Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study." GROWTH HORMONE & IGF RESEARCH , vol.67.
@article{article, author={Elif Durmuş Çalışkan Et Al. }, title={Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study}, journal={GROWTH HORMONE & IGF RESEARCH}, year=2022}